Advertisement
UK markets closed
  • FTSE 100

    8,317.59
    -21.64 (-0.26%)
     
  • FTSE 250

    20,770.93
    +139.63 (+0.68%)
     
  • AIM

    810.02
    +5.00 (+0.62%)
     
  • GBP/EUR

    1.1744
    +0.0007 (+0.06%)
     
  • GBP/USD

    1.2744
    +0.0005 (+0.04%)
     
  • Bitcoin GBP

    53,756.16
    -550.28 (-1.01%)
     
  • CMC Crypto 200

    1,488.09
    +3.90 (+0.26%)
     
  • S&P 500

    5,304.72
    +36.88 (+0.70%)
     
  • DOW

    39,069.59
    +4.29 (+0.01%)
     
  • CRUDE OIL

    77.89
    +0.17 (+0.22%)
     
  • GOLD FUTURES

    2,341.80
    +7.30 (+0.31%)
     
  • NIKKEI 225

    38,900.02
    +253.91 (+0.66%)
     
  • HANG SENG

    18,850.46
    +241.52 (+1.30%)
     
  • DAX

    18,699.98
    +6.61 (+0.04%)
     
  • CAC 40

    8,091.16
    -3.81 (-0.05%)
     

Kenvue to Announce First Quarter 2024 Results on May 7, 2024

SKILLMAN, N.J., April 05, 2024--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) ("Kenvue"), the world’s largest pure-play consumer health company by revenue, will announce its financial results for the first quarter ending March 31, 2024, before market open on May 7, 2024.

The company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the financial results. The conference call can be accessed by dialing 888-672-2415 from the U.S. or +1 646-307-1952 from international locations. The conference ID for all callers is 14840. A live webcast of the conference call will be available at investors.kenvue.com. A replay will be available after the live event.

About Kenvue

Kenvue is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand Adhesive Bandages, Johnson’s®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers’ hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.

ADVERTISEMENT

View source version on businesswire.com: https://www.businesswire.com/news/home/20240405952689/en/

Contacts

Investor Relations:
Tina Romani
Kenvue_IR@kenvue.com

Media Relations:
Melissa Witt
media@kenvue.com